Apotex Health Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024
Period Ending	Jun '26 Jun 11, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Debt / Equity Ratio	-6.31	-6.31	9.12	2.56
Debt / EBITDA Ratio	2.89	2.89	2.34	2.40
Debt / FCF Ratio	6.77	6.77	5.75	3.84
Net Debt / Equity Ratio	-6.21	-6.21	8.85	1.98
Net Debt / EBITDA Ratio	2.91	2.91	2.33	1.94
Net Debt / FCF Ratio	6.66	6.66	5.58	2.98
Asset Turnover	0.74	0.74	0.75	-
Inventory Turnover	1.63	1.63	1.69	-
Quick Ratio	0.77	0.77	0.65	1.02
Current Ratio	1.50	1.50	1.39	1.83
Return on Equity (ROE)	-	-	29.65%	-
Return on Assets (ROA)	14.24%	14.24%	14.03%	-
Return on Invested Capital (ROIC)	26.67%	26.67%	19.31%	28.78%
Return on Capital Employed (ROCE)	34.60%	34.60%	31.30%	23.30%
Payout Ratio	296.87%	296.87%	108.08%	-
Buyback Yield / Dilution	-	-1.77%	-6.11%	-